Cantor Fitzgerald Initiates Coverage of Capricor Therapeutics (CAPR) with Overweight Recommendation
Fintel reports that on January 5, 2024, Cantor Fitzgerald initiated coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Overweight recommendation. Analyst Price Forecast Suggests 319.52% Upside As of December 16, 2023,…